Becton Dickinson BDX
NYSE BDX
$176.42 -3.38 (-1.88%)
As of: Sep 10, 2026 · 3:59 PM EDT

Becton Dickinson (BDX) Total Non-Current Liabilities (2009 - 2026)

Becton Dickinson's (BDX) quarterly Total Non-Current Liabilities came in at $23.9 billion in Q2 2026, down 10.07% year-over-year from $26.6 billion in Q2 2025, and down 1.31% quarter-over-quarter from $24.2 billion in Q1 2026.

Analysis

Becton Dickinson (BDX) Total Non-Current Liabilities (2009 - 2026) Analysis & Trends

Becton Dickinson (BDX) has reported Total Non-Current Liabilities for 18 consecutive years, with $23.9 billion the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Total Non-Current Liabilities fell 10.07% year-over-year to $23.9 billion in Q2 2026; TTM through Jun 2026 was $23.9 billion, a 10.07% decrease from a year earlier, with the FY2025 full-year figure at $27.3 billion, down 1.92% from the prior year.
  • Total Non-Current Liabilities was $23.9 billion for Q2 2026 at Becton Dickinson, down from $24.2 billion in the prior quarter.
  • Over five years, Total Non-Current Liabilities peaked at $27.8 billion in Q3 2024 and troughed at $22.4 billion in Q3 2023.
  • A 5-year average of $24.7 billion and a median of $24.2 billion in 2023 frame the typical range for Total Non-Current Liabilities.
  • Across the five-year window, Total Non-Current Liabilities advanced 24.27% in 2024 and retreated 10.07% in 2026, its largest moves.
  • Over 5 years, Total Non-Current Liabilities stood at $22.8 billion in 2022, then declined by 1.17% to $22.5 billion in 2023, then grew by 15.6% to $26.0 billion in 2024, then rose by 2.7% to $26.7 billion in 2025, then fell by 10.56% to $23.9 billion in 2026.
  • The last three Total Non-Current Liabilities figures came in at $23.9 billion (Q2 2026), $24.2 billion (Q1 2026), and $26.7 billion (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Becton Dickinson 48.41 Bn 47.55 Bn 2.32 Bn 23.92 Bn
2 Medline 27.78 Bn 25.10 Bn 2.22 Bn 17.56 Bn
3 West Pharmaceutical Services 24.42 Bn 23.98 Bn 329.20 Mn 996.30 Mn
4 Baxter International 12.49 Bn 10.34 Bn 1.03 Bn 12.41 Bn
5 Stevanato Group S.p.A 5.70 Bn 5.59 Bn 100.91 Mn -89.27 Mn
6 Acme United 235.29 Mn 230.25 Mn 26.69 Mn 75.19 Mn
7 Rockwell Medical 31.39 Mn 6.60 Mn 3.24 Mn -
8 Retractable Technologies 21.15 Mn -18.72 Mn 190,852.00 13.70 Mn
9 United Health Products 8.85 Mn 8.82 Mn - 4.54 Mn
10 Cuprina Holdings (Cayman) 7.88 Mn 4.76 Mn - 333,758.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 23.92 Bn
Mar 31, 2026 24.24 Bn
Dec 31, 2025 26.74 Bn
Sep 30, 2025 27.30 Bn
Jun 30, 2025 26.60 Bn
Mar 31, 2025 26.23 Bn
Dec 31, 2024 26.04 Bn
Sep 30, 2024 27.84 Bn
Jun 30, 2024 25.64 Bn
Mar 31, 2024 24.21 Bn
Dec 31, 2023 22.53 Bn
Sep 30, 2023 22.40 Bn
Jun 30, 2023 22.71 Bn
Mar 31, 2023 24.23 Bn
Dec 31, 2022 22.80 Bn
Sep 30, 2022 22.60 Bn
Jun 30, 2022 22.77 Bn
Mar 31, 2022 25.29 Bn
Dec 31, 2021 24.17 Bn
Sep 30, 2021 24.98 Bn